Ode Pharma
Ode Pharma – Lung Medicine to Japan
Problem / difficulty
A long process and high budget to go the path of licensing a drug in Japan involving clinical trials in most cases.
challenge
Choosing the right path, with the right partners, to work parallel to get the certification needed during the pandemic.
solution
Extensive research led to steps such as converting food additives while working on medical procedures. We found that the product ingredient was on the Ministry of Health’s safe list; therefore, we could complete the clinical trial while distributing the product as a food additive. Because the additive was on the safe list, we were able to support a trial of 180,000 supplement doses – 3000 employees with 60 pills each.
ABOUT THE PRODUCT
other Case studies
SERVICES
© 2024K.I.N Co.,Ltd Kyoto International Network. All rights reserved.
